Regarding chemokine receptors, ZDHHC19 displayed a generally positive correlation with chemokine receptors in most cancers, except for adrenocortical carcinoma, endometrial carcinoma, uterine sarcoma, and uveal melanoma, where it was negatively correlated with chemokine receptors (Figure 8d,e). This evidence concerns the gene ZDHHC19 and uveal melanoma.